	Exploring UK breastmilk donors' perspectives on breastfeeding as a protective factor against breast cancer: a qualitative study. BMJ Open D'Alessandro S, Griffin S, Weaver G, Flanagan JM, Brown A. PMID: 42810788 [PubMed - indexed for MEDLINE]
	Combined mastectomy and beating heart coronary artery bypass grafting: a single-session surgical approach. BMJ Case Rep Abbasoglu P, Gider V, Deniz E, Bas. PMID: 42810747 [PubMed - indexed for MEDLINE]
	Effectiveness of an exercise intervention on cognition in breast cancer survivors: a randomized controlled trial. J Natl Cancer Inst Hartman SJ, Shao LY, Zablocki RW, Natarajan L, Ahles T, Palmer BW, Sears DD, Tam RM, Mac V, Dillon L, Yan C, Parker BA. PMID: 42810736 [PubMed - as supplied by publisher]
	Exercise slows biological aging in breast cancer survivors: secondary analysis of a randomized trial. J Natl Cancer Inst Carlin D, Ott O, Sears DD, Ahles T, Desplats P, Hartman SJ. PMID: 42810733 [PubMed - as supplied by publisher]
	Abundance is not survival: intratumoural immune-cell fate as a missing endpoint in antibody-drug conjugate and checkpoint blockade combinations for triple-negative breast cancer. Crit Rev Oncol Hematol Dong Z, Zhao Y, Pei W, Liu Z, Sun L. PMID: 42810559 [PubMed - as supplied by publisher]
	Clinical Implications of the Type and Genomic Location of Pathogenic BRCA1 and BRCA2 Variants in Hereditary Breast and Ovarian Cancer. Crit Rev Oncol Hematol Zattarin E, Piombino C, Tenedini E, Siciliano F, Galasso I, Barbieri E, Grippa M, Zaniboni S, Ponzoni O, Mandó P, Lambertini M, Blondeaux E, Tagliafico E, Piacentini F, Yadav S, Grandi G, Dominici M, Cortesi L, Toss A. PMID: 42810557 [PubMed - as supplied by publisher]
	Total saponins from Paris polyphylla against breast cancer: an integrative pharmacological study combining chemical profiling, network pharmacology, machine learning, and in vitro validation. J Ethnopharmacol Huang HT, Zhou LP, Chen Q, Wang WQ, Yao SC, Zhang HJ, Li YX, Qu CH, Yin XB, Ni J, Dong XX. PMID: 42810458 [PubMed - as supplied by publisher]
	Tucatinib, trastuzumab, and capecitabine as second- or third-line therapy after trastuzumab deruxtecan in HER2-positive metastatic breast cancer: A multicenter retrospective study in France. Breast Frenel J, de Nonnevile A, Guerin-Charbonnel C, Zeghondy J, Mathiot L, Mailliez A, Poumeaud F, Isambert N, Arnedos M, Le Du F, Galland L, Kabirian R, Guiu S, Poestch L, Deluche E, Cherifi F, Dalenc F, Volant E, Pistilli B, San T, Bachelot T, Patsouris A, Bocquet F, Bailleux C, Loirat D, Larrouquere L. PMID: 42810229 [PubMed - as supplied by publisher]
	Analysis of outcomes of nab-paclitaxel compared to other taxanes in early breast cancer: A study revealing the critical role of calendar-time bias in real-world drug comparisons. Breast Xiao J, Huang M, Yan C, Wang Z, Wang T. PMID: 42810228 [PubMed - as supplied by publisher]
	Immediate breast reconstruction by exclusive autologous fat grafting after prophylactic mastectomy: A quantitative and qualitative study. J Plast Reconstr Aesthet Surg Giaoui G, Serror K, Brand S, Mulier G, Chaouat M, Boccara D. PMID: 42810151 [PubMed - as supplied by publisher]
	Reflections on adjuvant pembrolizumab for triple-negative breast cancer treated with the KEYNOTE-522 regimen: Is it really necessary? Eur J Cancer Liutti VT, Wildiers H, Sonke GS, Neven P. PMID: 42810150 [PubMed - as supplied by publisher]
	A phase I, first-in-human dose-escalation and triple-negative breast cancer dose-expansion study of a TROP2-ADC F0024 (FDA018). Eur J Cancer Du Y, Meng Y, Liu X, Wang J, Wang Y, Wu F, Chen Y, Chen L, Qing L, Sun W, Liu K, Zhang J. PMID: 42810148 [PubMed - as supplied by publisher]
	Risk factors for idiopathic granulomatous mastitis: scoping review. BJS Open Castelhano RSS, Argus L, Ahari D, Johri G, MacInnes E, Shah S, Darlow C, Sharma V, Shukla R, Lyburn I, Sharma N, Bradley R, Kirwan CC. PMID: 42809717 [PubMed - indexed for MEDLINE]
	Efficacy and safety of T-DXd versus Other HER2-targeted therapies in second-line and later settings for HER2-positive metastatic breast cancer: A Bayesian network meta-analysis. PLoS One Xiao Y, Fu J, Li J, Hu G. PMID: 42809558 [PubMed - indexed for MEDLINE]
	Cytology of axillary breast carcinoma metastasis with squamous features - a morphological spectrum of diagnostically problematic aspirates. Acta Cytol Ng JKM, Cheung BHC, Cheung EKC, Tao LTS, Kwong A, Li J. PMID: 42809501 [PubMed - as supplied by publisher]
	Reply: Adipose-Derived Stem Cell-Enhanced versus Conventional Fat Grafting for Breast Reconstruction: A Systematic Review and Meta-Analysis. Plast Reconstr Surg Shimizu Y, Inoue Y, Sowa Y, Matsuura N, Matsuura R, Asato R, Nagatsuka T, Sunami H, Ntege EH. PMID: 42809332 [PubMed - in process]
	Biologic Matrices and Synthetic Meshes in Breast Aesthetic and Reconstructive Surgery. Plast Reconstr Surg Tanna N, Smith IT, Rothchild E, Odoom G, Zhang BH. PMID: 42809323 [PubMed - indexed for MEDLINE]
	AMCP Market Insights: Managed care approaches to ESR1-mutated advanced breast cancer. J Manag Care Spec Pharm Flavin B, Tweed C, Evans J, Fleszar SL, Gandhi G, Hanna KS, Haumschild R, O'Shea T, Richardson T, Valbh T, Wolff D. PMID: 42809213 [PubMed - indexed for MEDLINE]
	Language Barriers and Breast Reconstruction Decision-Making-A Literature Review and Exploratory Analysis. J Racial Ethn Health Disparities Brammer I, Mahajan A, Patel A. PMID: 42809205 [PubMed - as supplied by publisher]
	Incidence and associated factors of medication-related osteonecrosis of the jaw in breast cancer patients with bone metastases: a nationwide registry study in Finland. Clin Oral Investig Kujanpää M, Vuollo V, Tiisanoja A, Laitala ML, Koivunen J, Sándor GK, Karki S. PMID: 42809145 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 222576

Page 1 of 11129



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy